Literature DB >> 31361490

FAME 3: Predicting the Sites of Metabolism in Synthetic Compounds and Natural Products for Phase 1 and Phase 2 Metabolic Enzymes.

Martin Šícho1,2, Conrad Stork1, Angelica Mazzolari3, Christina de Bruyn Kops1, Alessandro Pedretti3, Bernard Testa4, Giulio Vistoli3, Daniel Svozil2, Johannes Kirchmair1.   

Abstract

In this work we present the third generation of FAst MEtabolizer (FAME 3), a collection of extra trees classifiers for the prediction of sites of metabolism (SoMs) in small molecules such as drugs, druglike compounds, natural products, agrochemicals, and cosmetics. FAME 3 was derived from the MetaQSAR database ( Pedretti et al. J. Med. Chem. 2018 , 61 , 1019 ), a recently published data resource on xenobiotic metabolism that contains more than 2100 substrates annotated with more than 6300 experimentally confirmed SoMs related to redox reactions, hydrolysis and other nonredox reactions, and conjugation reactions. In tests with holdout data, FAME 3 models reached competitive performance, with Matthews correlation coefficients (MCCs) ranging from 0.50 for a global model covering phase 1 and phase 2 metabolism, to 0.75 for a focused model for phase 2 metabolism. A model focused on cytochrome P450 metabolism yielded an MCC of 0.57. Results from case studies with several synthetic compounds, natural products, and natural product derivatives demonstrate the agreement between model predictions and literature data even for molecules with structural patterns clearly distinct from those present in the training data. The applicability domains of the individual models were estimated by a new, atom-based distance measure (FAMEscore) that is based on a nearest-neighbor search in the space of atom environments. FAME 3 is available via a public web service at https://nerdd.zbh.uni-hamburg.de/ and as a self-contained Java software package, free for academic and noncommercial research.

Entities:  

Year:  2019        PMID: 31361490     DOI: 10.1021/acs.jcim.9b00376

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  11 in total

1.  The Therapeutic Potential of 2-{[4-(2-methoxyphenyl)piperazin-1-yl]alkyl}-1H-benzo[d]imidazoles as Ligands for Alpha1-Adrenergic Receptor - Comparative In Silico and In Vitro Study.

Authors:  Jelena Z Penjišević; Vladimir B Šukalović; Deana B Andrić; Relja Suručić; Sladjana V Kostić-Rajačić
Journal:  Appl Biochem Biotechnol       Date:  2022-05-04       Impact factor: 3.094

2.  Discovery and Anticancer Activity of Novel 1,3,4-Thiadiazole- and Aziridine-Based Indolin-2-ones via In Silico Design Followed by Supramolecular Green Synthesis.

Authors:  Prashant J Chaudhari; Sanjaykumar B Bari; Sanjay J Surana; Atul A Shirkhedkar; Chandrakant G Bonde; Saurabh C Khadse; Vinod G Ugale; Akhil A Nagar; Rameshwar S Cheke
Journal:  ACS Omega       Date:  2022-05-12

3.  A study of deregulated MMR pathways and anticancer potential of curcuma derivatives using computational approach.

Authors:  Priyanjali Bhattacharya; Trupti N Patel
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

4.  Homotropic Cooperativity of Midazolam Metabolism by Cytochrome P450 3A4: Insight from Computational Studies.

Authors:  Junhao Li; Yue Chen; Yun Tang; Weihua Li; Yaoquan Tu
Journal:  J Chem Inf Model       Date:  2021-04-22       Impact factor: 4.956

5.  CyProduct: A Software Tool for Accurately Predicting the Byproducts of Human Cytochrome P450 Metabolism.

Authors:  Siyang Tian; Xuan Cao; Russell Greiner; Carin Li; AnChi Guo; David S Wishart
Journal:  J Chem Inf Model       Date:  2021-05-26       Impact factor: 6.162

6.  Novel advances in biotransformation and bioactivation research - 2020 year in review.

Authors:  S Cyrus Khojasteh; Upendra A Argikar; James P Driscoll; Carley J S Heck; Lloyd King; Klarissa D Jackson; Wenying Jian; Amit S Kalgutkar; Grover P Miller; Valerie Kramlinger; Ivonne M C M Rietjens; Aaron M Teitelbaum; Kai Wang; Cong Wei
Journal:  Drug Metab Rev       Date:  2021-06-24       Impact factor: 6.984

7.  Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites.

Authors:  Tyler B Hughes; Na Le Dang; Ayush Kumar; Noah R Flynn; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2020-09-16       Impact factor: 4.956

8.  XenoNet: Inference and Likelihood of Intermediate Metabolite Formation.

Authors:  Noah R Flynn; Na Le Dang; Michael D Ward; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2020-06-29       Impact factor: 4.956

9.  GLORYx: Prediction of the Metabolites Resulting from Phase 1 and Phase 2 Biotransformations of Xenobiotics.

Authors:  Christina de Bruyn Kops; Martin Šícho; Angelica Mazzolari; Johannes Kirchmair
Journal:  Chem Res Toxicol       Date:  2020-08-26       Impact factor: 3.739

10.  Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of Trypanosoma brucei Pteridine Reductase and Dihydrofolate Reductase.

Authors:  Giusy Tassone; Giacomo Landi; Pasquale Linciano; Valeria Francesconi; Michele Tonelli; Lorenzo Tagliazucchi; Maria Paola Costi; Stefano Mangani; Cecilia Pozzi
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.